Please check the following:
- {{x.value}}
FREE membership
FREE membership
Join Intelligent Investor today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
Log in
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Congratulations!
You now have free access to InvestSMART, we look forward to helping you on your financial journey.
You now have access to Free Eureka Report Insights, We look forward to helping you on your financial journey.
You now have access to Intelligent Investor Free Insights. We look forward to helping you build a market beating stock portfolio.
Looking for more…
Intelligent Investor Membership
15-day Free Trial
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
No thanks
Looking for more…
Eureka Report Membership
15-day Free Trial
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
No thanks
Anagenics Limited (ASX: AN1) - Share Price and Research
- Current share price for AN1 : $0.010
Anagenics Limited (AN1, formerly Cellmid Limited), an ASX-listed company, is a health and beauty-tech business growing through the global distribution and sales of its proprietary and licensed brands of differentiated, clinically validated anti-aging solutions. BLC Cosmetics Pty Ltd is Anagenics' wholly owned subsidiary focused on sales and distribution of Australian and international brands of cosmetic and wellness products. Advangen Pty Ltd is Anagenics' wholly owned subsidiary engaged in the development and sale of proprietary products for hair, skin and body.
AN1 General Information +
| ASX Code | AN1 |
| Website | http://www.anagenics.com |
| Industry/Sector | Personal Products |
| Market Cap ($M) | 4 |
| AN1 Share Price | $0.010 |
| Day High | $0.011 |
| Day Low | $0.010 |
| Last Close | $0.010 |
| AN1 Share Price Movement | - ( No change ) |
Prices as at 10:51, 25 Apr 2024
+Security prices are delayed by at least 20 minutes and are indicative only.
AN1 Related Research
Anagenics Limited (AN1) Upcoming Dividends & Yields
There are no dividends for Anagenics Limited (AN1). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Anagenics Limited (AN1) Recent ASX Announcements
| Headline | Annoucement date/time+ | Price at announcement+ | Current price+ | Price 7D Avg | Gain/Loss |
|---|---|---|---|---|---|
| Change in substantial holding - HNG | 19 Apr 2024 9:17AM | $0.010 | $0.010 | $0.010 | fallen by 0% |
| Notification regarding unquoted securities - AN1 | 17 Apr 2024 12:00PM | $0.010 | $0.010 | $0.010 | fallen by 0% |
| Cleansing Notice | 17 Apr 2024 11:42AM | $0.010 | $0.010 | $0.010 | fallen by 0% |
- + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.
See all ASX announcements from Anagenics Limited (AN1) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.
AN1 Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2023A | -$0.51 | -$0.20 | -88.10% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2022A | -$3.37 | -$1.60 | -27.90% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2021A | -$3.17 | -$2.20 | -52.30% | 0.00 | 0.00 | 0.00% | 0.0% |
AN1 Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2021 A | 2022 A | 2023 A | 2021 A | 2022 A | 2023 A | 2021 A | 2022 A | 2023 A | ||
| Anagenics (AN1) | $4M | -0.8813 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
AN1 Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 0.41 | 0.00 |
| Market | 0.54 | 15.00 | 1.10 | 1.05 |
| Sector | 0.00 | 13.70 | 0.58 | 0.00 |
AN1 Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Scott Mitchell Greasley | Executive Director | 8 Jul 2022 |
| Ms Karen Anne Matthews | Non executive director, Chief Executive Officer | 14 Feb 2023 |
| Mr Alexander (Sandy) Damien Harry Beard | Non-Executive Chairman, Non-Executive Director | 15 Feb 2022 |
| Mr Phillip Christopher | Non-Executive Director | 5 Nov 2021 |
Anagenics Limited (AN1) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 11 Mar 2024 | BEARD, Alexander (Sandy) | Buy | Indirect Shares | 66,133 | $0.015 | $991.990 |
| 8 Mar 2024 | BEARD, Alexander (Sandy) | Buy | Indirect Shares | 463,287 | $0.015 | $6,846.140 |
| 7 Mar 2024 | BEARD, Alexander (Sandy) | Buy | Indirect Shares | 440,680 | $0.014 | $6,234.990 |
See all changes in directors' interest & trades for Anagenics Limited (AN1) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
AN1 Management
| Name | Position |
|---|---|
| Matthew Dudek | Chief Financial Officer,Company Secretary |
| Lee Tamplin | Company Secretary |
AN1 Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Anagenics Limited (AN1). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 173,294,460 (47.39%) | HGL Limited |
| 19,196,581 (5.25%) | Dennis Keith Eck |
FAQs about Anagenics Limited (AN1)
What is the current share price of Anagenics Limited (AN1)?
Anagenics Limited's (AN1) current share price is $0.01. This constitutes a price movement of 0% when compared to the share price 7 days ago and is -61.54% below AN1's 12-month high of $0.03 per share. Prices are delayed by at least 20 minutes.
What is the share price movement for Anagenics Limited (AN1)?
Relative to the previous close share price of $0.01, Anagenics Limited's (AN1) current share price of $0.01 constitutes a movement of or 0%. Anagenics Limited's (AN1) share price movement is 0% when compared to 7 days ago and is -61.54% below AN1's 52-week high of $0.03.
What is the 52-week high share price for Anagenics Limited (AN1)?
Anagenics Limited's (AN1) 52-week high is $0.03 which was reached on 26 Apr 2023. Relative to this, AN1's current share price of $0.01 constitutes a -$0.02 or -61.54% drop since that high of $0.03 per AN1 share.
What is the 52-week low share price for Anagenics Limited (AN1)?
Anagenics Limited's (AN1) 52-week low is $0.01 which was reached on 19 Apr 2024. Relative to this, AN1's current share price of $0.01 constitutes a $0.00 or 11.11% gain since that low of $0.01 per AN1 share.
What is the daily average trading volume for Anagenics Limited (AN1)?
Over the last 12 months, Anagenics Limited (AN1) has a daily average trading volume of 172,036 AN1 shares per day.
What is the dividend yield for Anagenics Limited (AN1)?
Anagenics Limited (AN1) has a current dividend yield of n/a this year. Last year's dividend yield was 0%. The dividend yield for AN1 is a ratio that tells you the percentage of Anagenics Limited's (AN1) share price that it pays out in dividends each year.
When does Anagenics Limited (AN1) release its next Annual Report?
Anagenics Limited (AN1) will release its next Annual Report on n/a. Anagenics Limited's (AN1) last annual report was released on 11 Oct 2023. Click here to view Anagenics Limited's (AN1) last annual report.
In which sector is Anagenics Limited (AN1) classified?
Anagenics Limited (AN1) is classified as Consumer Staple. Other companies in this sector include Woolworths Group Limited (WOW), Coles Group Limited (COL), Treasury Wine Estates Limited (TWE), and Endeavour Group Limited (EDV).
What is the price-to-earnings (P/E) ratio for Anagenics Limited (AN1)?
The price-to-earnings (P/E) ratio for Anagenics Limited (AN1) is 0. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of Anagenics Limited's (AN1) share price to its earnings per AN1 share.
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
